EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Milk Extracellular Vesicle‐Based Nanoplatform Enhances Combination Therapy Against Multidrug‐Resistant Bacterial Infections

Shaoqi Qu iD, Shuo Yang, Qingjun Xu, Mengying Zhang, Feng Gao, Yongning Wu, Lin Li

Advanced Science · 2025-02 · 12 (7)

DOI: 10.1002/advs.202406496 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 25.12.2024. Verfasst von Shaoqi Qu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Animal-Derived Food Safety Innovation Team, College of Veterinary Medicine, Anhui Agricultural University, Hefei, 230036, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents, Milk. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Outstanding Youth Scientific Research Foundation of the Anhui Education Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing occurrence of infections caused by multidrug‐resistant (MDR) bacteria drives the need for new antibacterial drugs. Due to the current lack of antibiotic discovery and development, new strategies to fight MDR bacteria are urgently needed. Efforts to develop new antibiotic adjuvants to increase the effectiveness of existing antibiotics and design delivery systems are essential to address this issue. Here, a bioinspired delivery system equipped with combination therapy and paracellular transport is shown to enhance the efficacy against bacterial infections by improving oral delivery. A screening platform is established using an in vitro‐induced high polymyxin‐resistant strain to acquire plumbagin, which enhances the efficacy of polymyxin. Functionalized milk extracellular vesicles (FMEVs) coloaded with polymyxin and plumbagin cleared 99% of the bacteria within 4 h. Mechanistic studies revealed that the drug combination damaged the membrane, disrupted energy metabolism, and accelerated bacterial death. Finally, FMEVs are efficiently transported transcellularly through the citric acid‐mediated reversible opening of the tight junctions and showed high efficacy against an MDR Escherichia coli ‐associated peritonitis–sepsis model in mice. These findings provide a potential therapeutic strategy to improve the efficacy of combination therapy by enhancing oral delivery using a biomimetic delivery platform.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesDrug Resistance, Multiple, BacterialAnti-Bacterial AgentsMilkBacterial InfectionsAnimalsMiceDrug Therapy, CombinationEscherichia coliDrug Delivery SystemsPolymyxinsDisease Models, AnimalNaphthoquinonesHumans

Stichwörter der Autor:innen

bacteriamilk extracellular vesiclesmultidrug resistanceplumbaginpolymyxin

Substanzen

Anti-Bacterial AgentsplumbaginPolymyxinsNaphthoquinones

Autor:innen und Institutionen

  • Animal-Derived Food Safety Innovation Team, College of Veterinary Medicine, Anhui Agricultural University, Hefei, 230036, China.
  • Research Unit of Food Safety, Chinese Academy of Medical Sciences (No. 2019RU014), NHC Key Laboratory of Food Safety Risk Assessment, China National Center for Food Safety Risk Assessment (CFSA), Beijing, 100022, China.

ORCID-Profile: Shaoqi Qu

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Outstanding Youth Scientific Research Foundation of the Anhui Education Department

Zitieren

APA

Qu, S., Yang, S., Xu, Q., Zhang, M., Gao, F., Wu, Y., & Li, L. (2025). A Milk Extracellular Vesicle‐Based Nanoplatform Enhances Combination Therapy Against Multidrug‐Resistant Bacterial Infections. Advanced Science, 12(7). https://doi.org/10.1002/advs.202406496

Vancouver

Qu S, Yang S, Xu Q, Zhang M, Gao F, Wu Y, et al. A Milk Extracellular Vesicle‐Based Nanoplatform Enhances Combination Therapy Against Multidrug‐Resistant Bacterial Infections. Advanced Science. 2025;12(7). doi:10.1002/advs.202406496

BibTeX
@article{Qu2025,
  author = {Qu, Shaoqi and Yang, Shuo and Xu, Qingjun and Zhang, Mengying and Gao, Feng and Wu, Yongning and Li, Lin},
  title = {A Milk Extracellular Vesicle‐Based Nanoplatform Enhances Combination Therapy Against Multidrug‐Resistant Bacterial Infections},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {7},
  doi = {10.1002/advs.202406496}
}
Kostenlos starten →